Eurofins raises 600M euros in public bond issue

By LabPulse.com staff writers

June 21, 2022 -- Bioanalytical testing firm Eurofins Scientific on Tuesday announced it has raised 600 million euros ($632.1 million) in a senior, unsecured public bond issue.

The bonds have a seven-year maturity, due on July 6, 2029, and will bear an annual fixed-rate coupon of 4%.

The Luxembourg-based firm said the transaction was oversubscribed. It will use the bond proceeds to manage the repurchase of 300 million euro fixed-to-floating rate bonds issued September 11, 2019 and 300 million euro fixed-to-floating rate bonds issued April 29, 2015 that are currently under tender offers, the firm said.

Eurofins, Cornell team up for blood test on COVID damage
Eurofins Viracor recently entered into an exclusive license agreement with Cornell University to commercialize assays for clinically managing COVID-19...
Eurofins to conduct U.K. genotyping research program
Eurofins Genomics will genotype 5 million consenting participants in support of the Our Future Health program, a genotyping research program in the U.K.
Eurofins subsidiary launches at-home test for 'forever chemicals'
Eurofins Scientific subsidiary EmpowerDX has launched a new at-home blood test to detect and measure more than 40 per- and polyfluorinated alkyl substances...
Eurofins unit partners with Gingko on COVID-19 testing
Eurofins Scientific subsidiary Clinical Enterprise and Ginkgo Bioworks have formed a partnership to support a federally funded COVID-19 polymerase chain...
Eurofins debuts 2 combined tests for COVID/influenza, RSV
Eurofins Technologies has launched two new reverse transcription polymerase chain reaction tests for the simultaneous detection of SARS-CoV-2, influenza...

Copyright © 2022 LabPulse.com

Last Updated mp 6/21/2022 1:43:54 PM